Regencell Bioscience ($RGC): Is this company just a huge scam?

This Chinese stock focused on herbal Traditional Chinese Medicine is pre-revenue and it's market cap sky rocketed in the past few days after stock split. Seems like a huge scam and potentially a short squeeze with all this short interest. What do y'all think?

2 Comments
 

Based on the most helpful WSO content, there isn't specific information about Regencell Bioscience ($RGC) in the provided dataset. However, the situation you describe—pre-revenue companies with skyrocketing market caps, stock splits, and high short interest—often raises red flags for potential speculative trading or short squeezes.

For companies like this, it's crucial to evaluate: 1. Business Fundamentals: Pre-revenue companies are inherently risky. Investigate their pipeline, cash situation, and any tangible progress toward commercialization. 2. Market Behavior: Sudden spikes in market cap, especially post-stock split, can sometimes be driven by speculative trading rather than fundamentals. 3. Short Interest: High short interest can lead to short squeezes, where rapid price increases are fueled by short sellers covering their positions.

If you're considering an investment or short position, proceed with caution and conduct thorough due diligence. For more insights, you might explore WSO threads on evaluating biotech or speculative stocks.

Sources: Guide To Evaluate a Biotech Company, https://www.wallstreetoasis.com/forum/hedge-fund/celh-celsius-holdings-a-massive-fraud?customgpt=1, Healthcare Overview... Part 1?, Unrest in the Middle Kingdom, and Anti-info in the Melting Pot | The Daily Peel | 11/29/22, What's your Top Stock Pick for 2017

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 
Most Helpful

Voluptatem nulla perspiciatis repudiandae voluptatum corrupti occaecati. Dolore deleniti possimus aliquam voluptatibus. Exercitationem quasi cum non aut.

Repellendus saepe dolore dolorem eaque. Incidunt maxime quasi saepe aperiam et quaerat.

Hic tempora accusantium suscipit voluptatem vero. Voluptatem placeat ducimus est maxime ex voluptatem enim.

Sunt id hic aut sed sed labore consequatur. Soluta molestiae perferendis ex voluptas omnis. Provident et beatae dolorem aliquid sed. Labore alias perspiciatis repudiandae voluptas.

 

Voluptas nostrum illum corporis dolores distinctio. Dignissimos voluptas nam doloribus. Architecto vitae maiores porro ducimus natus dolor quasi quia. Possimus quae temporibus doloribus quos. Adipisci eum aut laborum tenetur quia aliquam est. Hic perspiciatis perferendis aliquid quo.

Vel quia tempore est fugit voluptatibus quae qui. Iure placeat vitae distinctio quod. Et ipsam non enim voluptatum odit. Labore eaque quam eum suscipit ut non similique. Labore sed illum id eum distinctio cupiditate atque modi. Maiores est vitae at dolorem error cum omnis. Rem praesentium nisi rerum nulla mollitia expedita.

[Comment removed by mod team]
 

Quidem numquam modi quo omnis. Et sed accusantium eaque eveniet exercitationem. Autem doloribus sunt corporis dolorem voluptas sunt. Dignissimos odit explicabo aliquam dolore. Ut quia odit cumque quae velit. Dolorum et eum provident.

Autem natus et sunt. Ab ab numquam exercitationem similique.

Dolores ut ut a placeat quo. Libero aut et voluptate at ab. Deleniti impedit veniam architecto.

[Comment removed by mod team]

Career Advancement Opportunities

November 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.0%
  • AQR Capital Management 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Overall Employee Satisfaction

November 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.0%
  • Citadel Investment Group 96.0%
  • Two Sigma Investments 95.0%

Professional Growth Opportunities

November 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.1%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Total Avg Compensation

November 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (12) $355
  • NA (9) $320
  • Engineer/Quant (83) $287
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (77) $193
  • Analysts (235) $177
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (277) $95
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
DrApeman's picture
DrApeman
98.9
7
GameTheory's picture
GameTheory
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
dosk17's picture
dosk17
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”